Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Vivimed Labs Limited
Location
T. Score
Peers
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
People
Network
Registered Details

VIVIMED LABS LIMITED

www.vivimedlabs.com

Active

Updated: 05 Nov 2024

The company manufactures and sells specialty chemicals, dyes, and pharmaceutical ingredients in India,

Vivimed Labs Limited, is a listed public company incorporated on 22 September, 1988. It is classified as a public limited company and is located in Karnataka., Karnataka. It's authorized share capital is INR 111.00 cr and the total paid-up capital is INR 16.58 cr.

Industry

Agriculture and Allied Activities

Products

Finished Dosage Formulations, Active Pharma Ingredients (API), Specialty Chemicals.

Key Metrics

** All rupee values in INR crores. Based on March 2023 numbers.

Sales

-19.02%

₹ GET PRO

EBITDA

₹ GET PRO

Net Profit

₹ GET PRO

Networth

-70.85%

₹ GET PRO

Borrowings

5.52%

₹ GET PRO

Assets

-26.08%

₹ GET PRO

Gross Margin

-86.25

GET PRO %

Operating Margin

-102.2

GET PRO %

Net Profit Margin

-154.4

GET PRO %

Return on Equity

-231.22

GET PRO %

ROCE

-132.18

GET PRO %

Debt to Equity

2.05

GET PRO

Sales

Mar 2023

Net worth

Mar 2023

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

View subscriptions and buy credits

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
- Litigation and more
Due diligence report

₹ 2999
- Everything in financial report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (12)

State	Type	Address

Locations on Map

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Peers / Similar Companies

Indo Colchem Limited Gujarat

Oc Specialities Private Limited Maharashtra

Rieco Industries Limited Maharashtra

Caplet India Pvt.Ltd. West Bengal

Supreet Chemicals Limited Gujarat

Fishfa Biogenics Limited Gujarat

Nexus Drugs Private Limited Telangana

Peers

Indo Colchem Limited

Gujarat

Oc Specialities Private Limited

Maharashtra

Rieco Industries Limited

Maharashtra

Caplet India Pvt.Ltd.

West Bengal

Supreet Chemicals Limited

Gujarat

Fishfa Biogenics Limited

Gujarat

Nexus Drugs Private Limited

Telangana

Financial Highlights

Financials upto March 2023 available in Tofler Pro

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

Financials upto March 2023 available in Tofler Pro

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Equity Capital	16.5	16.6	16.6	16.6	16.6
Reserves	927.3	818.0	415.0	347.7	22.8
Borrowings +	757.1	888.9	253.0	358.9	378.6
Long term borrowings	424.8	470.4	57.8	61.0	62.3
Short term borrowings	332.3	418.5	195.2	297.9	316.2
Trade payables +	294.4	226.5	34.3	41.9	69.4
Days payable	207.0	179.0	35.0	100.0	93.0
Other liabilities +	628.3	486.1	604.7	542.8	570.4
Other non-current liabilities	71.6	134.3	458.9	467.3	462.3
Other current liabilities	262.2	125.3	111.6	33.6	38.6
Total liabilities	2,329.2	2,209.6	1,289.3	1,266.0	988.3
Fixed Assets +	1,087.2	1,134.4	561.8	559.9	456.5
Tangible assets	662.0	698.2	348.1	362.6	278.2
CWIP	122.3	89.3	60.1	40.0	20.7
Intangible assets	302.9	346.9	153.5	157.3	157.6
LT loans and advances	-	-	-	-	-
Other non-current assets	11.3	99.9	198.8	198.8	199.6
Current assets +	1,230.6	975.3	528.7	507.3	332.3
Inventories	563.7	501.9	255.7	240.8	79.8
Trade receivables	356.1	249.1	107.5	87.4	76.8
Cash and cash equivalents	94.5	50.5	6.4	7.2	3.8
ST loans and advances	75.7	79.3	95.1	42.9	39.8
Other current assets	140.6	94.5	64.0	129.0	132.2
Total assets	2,329.2	2,209.6	1,289.3	1,266.0	988.3

Percentage of assets	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Equity Capital	0.71	0.75	1.29	1.31	1.68
Reserves	39.81	37.02	32.19	27.46	2.31
Borrowings +	32.51	40.23	19.63	28.35	38.3
Long term borrowings	18.24	21.29	4.48	4.82	6.31
Short term borrowings	14.27	18.94	15.14	23.53	32.0
Trade payables	12.64	10.25	2.66	3.31	7.02
Other liabilities +	26.97	22.0	46.9	42.88	57.71
Other non-current liabilities	3.08	6.08	35.59	36.91	46.78
Other current liabilities	11.26	5.67	8.65	2.65	3.91
Total liabilities
Fixed Assets +	46.68	51.34	43.57	44.23	46.19
Tangible assets	28.42	31.6	27.0	28.64	28.15
CWIP	5.25	4.04	4.66	3.16	2.09
Intangible assets	13.0	15.7	11.91	12.43	15.95
LT loans and advances	0.0	0.0	0.0	0.0	0.0
Other non-current assets	0.49	4.52	15.42	15.7	20.19
Current assets +	52.83	44.14	41.01	40.07	33.62
Inventories	24.2	22.71	19.83	19.02	8.07
Trade receivables	15.29	11.27	8.34	6.9	7.77
Cash and cash equivalents	4.06	2.28	0.5	0.57	0.38
ST loans and advances	3.25	3.59	7.38	3.39	4.03
Other current assets	6.04	4.28	4.96	10.19	13.37
Total assets

Total assets

Profit & Loss

Standalone

Consolidated

₹

Financials upto March 2023 available in Tofler Pro

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Sales +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Sales growth %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Precentage of total income	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Sales +	1,315.2	1,058.8	861.5	237.3	187.1
Sales growth %	10.92	-19.49	-18.64	-72.46	-21.15
Expenses +	1,272.1	1,176.5	941.1	303.4	518.7
Cost of goods	518.4	462.6	354.5	153.5	271.5
Employee cost	241.8	233.4	189.7	36.2	32.7
Other costs	377.9	354.8	287.5	55.6	70.2
Operating profit +	177.1	8.1	29.7	-8.1	-187.3
Operating margin %	13.5	0.8	3.5	-3.4	-100.1
Other income	23.0	8.3	9.8	1.3	1.0
Interest	67.3	58.9	53.9	39.8	35.9
Depreciation	66.8	66.9	55.5	18.3	108.4
Exceptional items	-	-	-	-	-
Profit before tax	66.0	-109.5	-69.9	-64.8	-330.6
Tax	8.7	-0.4	2.0	2.8	-2.1
Profit - disc. ops	-	-	-	-	-
Net profit	57.4	-109.1	-71.9	-67.7	-328.5
Net margin %	4.3	-10.2	-8.2	-28.4	-174.7

Precentage of total income	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Sales	98.28	99.23	98.87	99.47	99.49
Expenses +	95.06	110.26	108.02	127.18	275.82
Cost of goods	38.74	43.35	40.69	64.34	144.37
Employee cost	18.07	21.87	21.78	15.18	17.37
Other costs	28.24	33.25	33.0	23.32	37.34
Operating profit	13.24	0.76	3.41	-3.38	-99.6
Other income	1.72	0.77	1.13	0.53	0.51
Interest	5.03	5.52	6.18	16.67	19.09
Depreciation	4.99	6.27	6.37	7.66	57.64
Exceptional items	0.0	0.0	0.0	0.0	0.0
Profit before tax	4.94	-10.26	-8.02	-27.18	-175.82
Tax	0.65	-0.03	0.23	1.18	-1.13
Profit - disc. ops	0.0	0.0	0.0	0.0	0.0
Net profit	4.29	-10.23	-8.25	-28.36	-174.69

Revenue from operations

Ratios

Standalone

Consolidated

Financials upto March 2023 available in Tofler Pro

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Solvency +
Total Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Debt/Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Assets/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Liquidity +
Current Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Quick Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest Coverage	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Performance
Gross Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return +
Return on Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROCE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return on Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROIC	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Efficiency +
Days Payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Inventory	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Receivable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital
Cash Conversion Cycle	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital Days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Solvency +
Total Debt/Equity	0.8	1.1	0.6	1.0	9.6
Net Debt/Equity	0.7	1.0	0.6	1.0	9.5
Total Debt/Assets	0.3	0.4	0.2	0.3	0.4
Total Assets/Equity	2.5	2.6	3.0	3.5	25.1
Liquidity +
Current Ratio	1.4	1.3	1.6	1.4	0.8
Quick Ratio	0.8	0.6	0.8	0.7	0.6
Interest Coverage	2.6	0.1	0.6	-0.2	-5.2
Performance
Gross Margin	60.6	56.3	58.9	35.3	-45.1
Operating Margin	13.5	0.8	3.5	-3.4	-100.1
Net Margin	4.3	-10.2	-8.2	-28.4	-174.7
Return +
Return on Equity	6.1	-13.1	-16.7	-18.6	-833.4
Pre-tax ROCE	7.7	-4.4	-3.4	-3.8	-81.1
Return on Assets	2.5	-4.9	-5.6	-5.3	-33.2
Pre-tax ROIC	6.9	-3.5	-3.8	-3.7	-71.4
Efficiency +
Days Payable	207.0	179.0	35.0	100.0	93.0
Days Inventory	397.0	396.0	263.0	573.0	107.0
Days Receivable	99.0	86.0	46.0	134.0	150.0
Fixed Asset Turnover	1.2	0.9	1.5	0.4	0.4
Total Asset Turnover	0.6	0.5	0.7	0.2	0.2
Working Capital
Cash Conversion Cycle	289.0	303.0	274.0	607.0	164.0
Working Capital Days	95.0	71.0	80.0	206.0	-180.0

Ratios

Current ratio

Debt/equity ratio

Charges on assets

Bank wise

Charges

State Bank of Hyderabad

No. of Loans: 6

Total Amount : 460.8 cr

State Bank of India

No. of Loans: 4

Total Amount : 310.6 cr

Allahabad Bank

No. of Loans: 1

Total Amount : 70.0 cr

INTERNATIONAL FINANCE CORPORATION

No. of Loans: 1

Total Amount : 62.5 cr

BANK OF BAHRAIN & KUWAIT B.S.C

No. of Loans: 1

Total Amount : 28.0 cr

Biotechnology Industry Research Assistance Council (BIRAC)

No. of Loans: 2

Total Amount : 0.5 cr

Corporation Bank

No. of Loans: 1

Total Amount : 0.2 cr

Charge Holder	Amount	Date of creation/modification
State Bank of India	232.0 cr	26 Jul, 2021
State Bank of India	15.0 cr	29 Jul, 2020
State Bank of India	4.5 cr	08 Nov, 2017
State Bank of Hyderabad	36.0 cr	08 Nov, 2016
State Bank of Hyderabad	36.0 cr	08 Nov, 2016
State Bank of India	59.1 cr	28 Oct, 2016
State Bank of Hyderabad	374.6 cr	28 Oct, 2016
BANK OF BAHRAIN & KUWAIT B.S.C	28.0 cr	30 Dec, 2015
Corporation Bank	0.2 cr	02 Apr, 2015
State Bank of Hyderabad	7.5 cr	05 Dec, 2014
State Bank of Hyderabad	5.8 cr	25 Sep, 2014
Biotechnology Industry Research Assistance Council (BIRAC)	0.2 cr	28 Jan, 2014
Biotechnology Industry Research Assistance Council (BIRAC)	0.2 cr	28 Jan, 2014
Allahabad Bank	70.0 cr	10 Jan, 2014
INTERNATIONAL FINANCE CORPORATION	62.5 cr	29 Jun, 2012
State Bank of Hyderabad	0.9 cr	11 Mar, 1993

Charges

State Bank of Hyderabad

State Bank of India

Allahabad Bank

INTERNATIONAL FINANCE CORPORATION

Others

People

Designation	Name	DIN/PAN	Tenure
Managing Director	Santosh Varalwar Shareholder	00054763	35 years
Director	Subhash Varalwar Shareholder	00054789	10 years
Whole-time Director	Manohar Rao Varalwar Shareholder	00059815	10 years
Whole-time Director	Sandeep Varalwar Shareholder	01682951	17 years
Director	Aparna Bidarkar	05112945	3 years
Director	Hari Gopal Jamalapuram	08687353	5 years
CS	Yugandhar Kopparthi	<HIDDEN>	12 years

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
KLAR SEHEN PVT LTD	Amalgamated	70.0 L	3	Karnataka
B B R PROJECTS PRIVATE LIMITED	Active	1.0 L	3	Telangana
CREATIVE HEALTHCARE PRIVATE LIMITED	Amalgamated	2.5 Cr	3	Maharashtra
ANAND EYE INSTITUTE PRIVATE LIMITED	Active	4.0 Cr	1	Telangana
KREATIVE HOSTS ATRIA PRIVATE LIMITED	Active	25.0 Cr	2	Telangana
ATRI PHARMA RESEARCH (INDIA) PRIVATE LIMITED	Active	47.8 L	1	Telangana
UQUIFA INDIA PRIVATE LIMITED	Active	1.0 L	1	Telangana
VIVIMED LABS (ALATHUR) PRIVATE LIMITED	Amalgamated	50.2 Cr	3	Maharashtra
V.V.S. PHARMACEUTICALS AND CHEMICALS PRI VATE LIMITED	Amalgamated	3.0 Cr	2	Telangana
DEMAS PROPERTIES & INFRASTRUCTURES PRIVATE LIMITED	Strike Off	1.0 L	1	Telangana
VIV LIFE LLP	Active	1.0 L	1	Telangana
LATTICE PROJEX PRIVATE LIMITED	Active	1.0 L	1	Telangana
HUE DESIGNERS PRIVATE LIMITED	Strike Off	6.7 L	1	Telangana

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
FINOSO PHARMA PRIVATE LIMITED	Telangana	2009	₹ 3.0 Cr
Vivimed Holdings Limited	Hong Kong	-	-
Vivimed Labs USA	United States	-	-
Vivimed Labs Mauritius Limited	Mauritius	-	-
YANTRA GREEN POWER PRIVATE LIMITED	Telangana	2013	₹ 15.0 Cr

Registered Details

CIN

L02411KA1988PLC009465

PAN

AAACV6060A

Incorporation

1988, 36.6 years

Company Email

yugandhar.kopparthi@vivimedlabs.com

Paid up Capital

₹ 16.6 Cr

Authorised Capital

₹ 111.0 Cr

AGM

Nov 2023

Type

Public

Non-government Company

FAQ - VIVIMED LABS LIMITED

What is the incorporation date of VIVIMED LABS LIMITED?

The incorporation date of VIVIMED LABS LIMITED is 22 September, 1988

What is the authorized share capital of VIVIMED LABS LIMITED?

The authorized share capital of VIVIMED LABS LIMITED is INR ₹ 111.0 Cr.

What is the paid-up capital of VIVIMED LABS LIMITED?

The paid-up capital of VIVIMED LABS LIMITED is INR ₹ 16.6 Cr.

What is the registered address of VIVIMED LABS LIMITED?

The registered address of VIVIMED LABS LIMITED is PLOT NO. 78-A,KOLHAR INDUSTRIAL AREA BIDAR KARNATAKA. Karnataka - 585403

What is the CIN number of VIVIMED LABS LIMITED?

The CIN number of VIVIMED LABS LIMITED is L02411KA1988PLC009465.

Smart Suggestions

Top Blog Post

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

VIVIMED LABS LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Industry

Buy Report or Plans

Dashboards

Company dashboard

View subscriptions and buy credits

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Due diligence report

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

Tofler Score

Risk

About Tofler Score

Peers / Similar Companies

Peers

Indo Colchem Limited

Oc Specialities Private Limited

Rieco Industries Limited

Caplet India Pvt.Ltd.

Supreet Chemicals Limited

Fishfa Biogenics Limited

Nexus Drugs Private Limited

Financial Highlights

Margins

Balance Sheet

Total assets

Profit & Loss

Revenue from operations

Ratios

Ratios

Charges on assets

Charges

People

Company Network